Drug Safety

share

Champions Oncology, a company engaged in the development and sale of advanced technology solutions and products to personalize...

share

Teva Pharmaceutical Industries announced the launch of generic Axiron®1 (testosterone) topical solution CIII, 30 mg/1.5 mL, in the...

share

A new consortium, led by Oxford BioMedica, will take part in a two-year, £2m project focused on gene...

share

Biognosys announced that it has secured USD 5m funding from new and existing investors in an extended series C...

share

HitGen Ltd announced that the company has entered into a multi-target multi-year collaboration with LEO Pharma A/S ,...

share

Soin Neuroscience, a biotech startup based in Dayton, OH, has recently signed a drug development deal with Cleveland...

share

Omeros Corporation announced that OMS721 has received orphan drug designation from the U.S. Food and Drug Administration (FDA) for the treatment...

share

AbbVie Inc said on Friday it had received European approval to market its drug for treatment of all...